UCB SA (EUR)
UCB
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range96.14 | 97.90
52-Wk Range- | -
Last Close97.78
Mkt Cap (m)18,492.09
Dividend yield1.27
ISINBE0003739530
Volume230,973.00
Exchange VenueBRU

Company Profile

UCB SA is engaged in the development of novel therapies for the treatment of central nervous system and immunological diseases.

Key Information
Price/Earning24.82
Price/Book2.61
Price/Sales3.54
P/CF20.26
Rev Growth (3 year avg)5.55
EPS Growth (3 year avg)0.15
Operating Margin % 21.84
Net Margin %16.12
Return on Equity11.87
Debt/Equity0.18

Documents

Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.ucb.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)3,344.003,876.004,178.004,530.004,632.004,913.00
Operating Income (m)409.00717.00967.001,137.001,163.001,073.00
Net Income (m)209.00623.00520.00753.00800.00792.00
Basic EPS1.103.252.764.004.244.23
Avg. Diluted Shares Outstanding (m)190.46192.08188.37188.28188.48187.22
Balance Sheet
EUR201420152016201720182019
Current Assets (m)2,501.002,838.002,331.002,677.002,950.003,295.00
Non Current Assets (m)7,647.008,118.007,881.007,240.007,564.007,785.00
Total Assets (m)10,148.0010,956.0010,212.009,917.0010,514.0011,081.00
Current Liabilities (m)2,336.003,061.002,418.001,949.002,238.002,394.00
Total Liabilities (m)------
Total Equity (m)5,002.005,672.005,584.005,813.006,310.007,039.00
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)512.00245.00427.00927.001,089.00882.00
Capital Expenditure (m)-161.00-146.00-138.00-209.00-341.00-294.00
Figures are quoted in EUR unless stated otherwise
-
No change
97.78
Last Price